Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial

Author:

Iavazzo Christos1,Gkegkes Ioannis D.23ORCID,Spiliotis John4ORCID

Affiliation:

1. Gynaecological Oncology Department , Metaxa Cancer Hospital , Piraeus , Greece

2. Athens Colorectal Laboratory , Athens , Greece

3. Department of Colorectal Surgery , Royal Devon and Exeter NHS Foundation Trust , Exeter , UK

4. Department of Surgical Oncology and HIPEC , European Interbalkan Medical Center , Thessaloniki , Greece

Publisher

Walter de Gruyter GmbH

Subject

Oncology,Surgery

Reference5 articles.

1. Charleux-Muller, D, Fabacher, T, Romain, B, Meyer, N, Brigand, C, Delhorme, JB. Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study. Pleura Peritoneum 2023;8:11–8. https://doi.org/10.1515/pp-2022-0133.

2. Hübner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) society recommendations – Part I: preoperative and intraoperative management. Eur J Surg Oncol 2020;46:2292–310. https://doi.org/10.1016/j.ejso.2020.07.041.

3. Hübner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) society recommendations – Part II: postoperative management and special considerations. Eur J Surg Oncol 2020;46:2311–23. https://doi.org/10.1016/j.ejso.2020.08.006.

4. Robella, M, Tonello, M, Berchialla, P, Sciannameo, V, Ilari Civit, AM, Sommariva, A, et al.. Enhanced recovery after surgery (ERAS) program for patients with peritoneal surface malignancies undergoing cytoreductive surgery with or without HIPEC: a systematic review and a meta-analysis. Cancers 2023;15:570. https://doi.org/10.3390/cancers15030570.

5. https://clinicaltrials.gov/study/NCT05185791 [Accessed 10 October 2023].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3